Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer

Completed · Phase 2

Conditions studied: Breast Cancer, Lung Cancer, Prostate Cancer

In brief

RATIONALE: Drugs used in chemotherapy, such as docetaxel, use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well docetaxel works in treating older patients with metastatic breast, lung, or prostate cancer.

Key facts

Study ID

NCT00059943

Run by

Memorial Sloan Kettering Cancer Center

Starts

2002-09-01

Last updated by the study team

2013-01-16

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Memorial Sloan-Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.